Norges Bank’s LB Pharmaceuticals LBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding LBRX
Norges Bank's LBRX Position: Q2 2026 in Review
Norges Bank sold out of LB Pharmaceuticals (LBRX) in Q2 2026, closing a stake of 20,000 shares — an estimated $445K sold.
Norges Bank first reported a position in LBRX in Q3 2025 and held it in 2 quarters. The position peaked at $445K in Q4 2025. 114 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.
- Norges Bank reported no remaining LB Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Norges Bank sold 20,000 LB Pharmaceuticals shares in Q2 2026, an estimated $445K.
- Norges Bank first reported a position in LB Pharmaceuticals in Q3 2025 and held it in 2 quarters.
- Norges Bank's LB Pharmaceuticals position peaked at $445K in Q4 2025.
- 114 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.
Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.